Mr. Andrew Midler serves as Managing Member at Savitr Capital, LLC which has its primary focus in health care venture investments. Mr. Midler founded the firm in 2008. Previously, Mr. Midler served as the Chief Executive Officer and Chief Investment Officer at Standard Pacific Capital. From 1986 to 1993, he worked as a Portfolio Manager at Fidelity Investments. Mr. Midler holds an M.B.A. from Harvard Business School. He earned M.A. and B.A. degrees in Political Science from Stanford University.
Dr. Pegus is the President of the American Heart Association (AHA) Founder's 2013. Previously she was the Chief Medical Officer for Walgreens. Dr. Pegus is a Director of Vision-Sciences, Inc. (Nasdaq:VCSI), Caluent and Glytec. She has served as the General Manager and Chief Medical Officer for Symcare, a J&J company that provides innovative care management solutions utilizing remote monitoring. Prior to Symcare, Dr. Pegus was the head of clinical products for Aetna's Medical Products business unit. She is a member of the Dean's Circle at Weill Cornell Medical College and a strategic advisor to HealthFleet, Inc.
Dr. Vogel was Vice President and Chief Information Officer at The University of Texas MD Anderson Cancer Center (UT-MDACC) in Houston, Texas. Previous CIO and IT VP leadership positions were at The University of Chicago Hospitals, and at Mount Sinai Medical Center and New York Presbyterian Healthcare in New York City. He has also served as a faculty member in Biomedical Informatics (Columbia University-New York City) and Bioinformatics/Computational Biology (UT-MDACC). For several years, Dr. Vogel served on the National Cancer Institute's National Cancer Advisory Board Informatics Working Group. He is a Member and Fellow (FHIMSS) of the Healthcare Information Management Systems Society (HIMSS), and a Fellow (FCHIME) and Life Fellow (LCHIME) of the College of Healthcare Information Management Executives (CHIME), where he was a Charter Member, and previously served as Board Member and Board Chair and was a faculty member of the CHIME CIO Boot Camp. Most recently he has worked with Encore Health Resources, has been a Senior Advisor to Sophic Alliance, and to Next Wave Health/Next Wave Connect, and currently works with Next Wave Health Advisors. Dr. Vogel's education at the bachelor's, masters and doctoral level was completed at The University of Chicago.
Dr. Scott Gottlieb is a physician and Resident Fellow at the American Enterprise Institute. From 2005-2007, Dr. Gottlieb served as FDA Deputy Commissioner for Medical and Scientific Affairs and before that, from 2003-2004, as a senior advisor to the FDA Commissioner, and as the FDA's Director of Medical Policy Development. Dr. Gottlieb left FDA in the spring of 2004 to work on implementation of the new Medicare Drug Benefit as a Senior Adviser to the Administrator of the Centers for Medicare and Medicaid Services, where he supported policy work on quality improvement and the agency's coverage process, particularly related to new medical technologies. Scott is an editorial board member of the journal Value Based Cancer Care, the Food and Drug Law Institute's Policy Forum, and is a member of the board of advisers of Cancer Commons. He is a member of the policy boards of the Society of Hospitalist Medicine, the Leukemia and Lymphoma Society, a venture partner to the venture capital firm New Enterprise Associates, and a member of the Product Investment Board of GlaxoSmithKline. He is also a Clinical Assistant Professor at the New York University School of Medicine in Manhattan. He completed a residency in internal medicine at the Mount Sinai Hospital in New York and is a graduate of the Mount Sinai School of Medicine and of Wesleyan University, in Middletown, Connecticut, where he studied Economics.
Dr. Eddie Floyd is the founder and president of Floyd Medical Associates in Florence, South Carolina. He is a graduate of the University of South Carolina and completed his internship and residence at Charity Hospital in New Orleans, Louisiana. Dr. Floyd is a Clinical Professor of Surgery, USC Medical School, Columbia, South Carolina, and a Clinical Professor of Surgery, MUSC Medical School, Charleston, South Carolina.
Mr. Frank started his investment career in 1979 as an analyst with Fidelity Management and Research "Fidelity Investments". In 1981, he became an assistant to Peter Lynch on Fidelity Magellan Fund, and in 1982, he formally launched his own fund "Fidelity Special Situations/Strategic Opportunities Fund" which grew to over $800 million. For the past decade Mr. Frank was a Managing Director at Cerberus Capital Management responsible for healthcare related investments, in both the public and private markets, from start-ups to established businesses in need of growth capital. In this role, he served as lead investor, co-investor, and various roles on the Board of Directors of the respective investments. The areas of focus encompassed diagnostics, specialty pharmaceuticals and medical devices.
Mr. Fulchino's experience spans 40 years as a business executive and strategic advisor to senior management. He has demonstrated a consistent record of achievement in his roles as Chairman, President and Chief Executive Officer of Aviall, Inc. (1999-2010), the world's largest aircraft parts service provider; President and Chief Operating Officer of B/E Aerospace (1996-1999), the largest aircraft interiors manufacturer; and as President and Vice Chairman of Mercer Management Consulting (now Oliver Wyman Associates) (1976-1996), one of the leading international consulting firms. In each of these entities, Mr Fulchino led the organizations to double digit annual growth in revenues and profitability. In addition to his public and private Company leadership roles, Mr. Fulchino serves on several Boards including Spirit Aerosystems, Wesco, Global Technology Systems and non-profit Boards such as the Boston College Athletic Advisory Council. His notable prior Board roles include The Sports Authority, Medsource Technologies and Mercer Consulting. Mr. Fulchino attended the United States Military Academy, received an A.B. in mathematics from Boston College, and earned his M.B.A. from Columbia University Graduate School of Business with a concentration in finance and operations research.
Mr. Rubin has extensive experience in investing in the public capital markets, investing in private debt and equity situations, structuring complex commercial and financial transactions and in the law. Most recently, Mr. Rubin was a Senior Managing Director and the Portfolio Manager for Black Diamond Capital Management L.L.C.'s hedge fund. Prior to that he was a Managing Director and Co-head of the Credit Group at Och-Ziff Capital Management Group L.L.C. where he managed the U.S. corporate credit portfolio. Prior to Och-Ziff, Mr. Rubin was a Managing Director at Cerberus Capital Management L.P. where he focused on special situation credits and private equity investing. Before that, Mr. Rubin was an Executive Director at CIBC World Markets where he published research on, and invested in, special situation opportunities. Mr. Rubin is a member of the New York State Bar and, prior to joining CIBC, actively practiced law primarily at Weil, Gotshal & Manges and Sullivan & Cromwell. In the past, Mr. Rubin has acted for the U.S. Securities & Exchange Commission as an independent hedge fund monitor. Mr. Rubin earned a J.D. from Columbia University Law School and a Bachelor of Science in Economics from the Wharton School of the University of Pennsylvania.
Bob Leonard is Glytec's CEO and also serves on the Board of Directors. Bob has over 25 years' experience in healthcare in various general management, senior sales and marketing positions. His experience encompasses information technology, hospital information systems, point-of-care devices, disease management and alternate site services; all relevant to the composition of Glytec's unique offering. Previous employers include, PatientKeeper, provider of physician healthcare information systems, which grew from zero to 450 hospital clients during his tenure; McKesson Information Systems, FluidSense (IV /fluid management) and Chartwell, a series of academic medical center partnerships focused on alternate site care. Bob has a proven track record of developing and leading high quality, high performance teams in fast growth companies. In his present role, as in several previous, Bob is responsible for developing and implementing the strategic vision of the company and more importantly, ensuring the company's culture is driven by an unwavering focus on the success and improved health of the hospitals and patients it was created to serve.